Allworth Financial’s Tevogen Inc TVGN Stock Holding History

Allworth Financial’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283	Buy	+50	New	+$399	﹤0.01%	4919

Other funds holding TVGN

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Allworth Financial's TVGN Position: Q2 2026 in Review

Allworth Financial opened a new position in Tevogen Inc (TVGN) in Q2 2026: 50 shares worth $283. The stake represents ﹤0.01% of the portfolio and ranks #4919 among its holdings.

31 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

Allworth Financial held 50 shares of Tevogen Inc worth $283 as of Q2 2026.
Tevogen Inc was a new Allworth Financial position in Q2 2026.
Tevogen Inc made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4919 holding.
31 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.